| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.498 | 14.394 | 16.809 | 18.378 | 17.272 | 12.932 | 16.991 | 18.031 | 19.709 | 19.819 |
| Total Income - EUR | 13.498 | 14.394 | 16.842 | 18.378 | 17.272 | 12.932 | 61.423 | 18.312 | 19.709 | 19.819 |
| Total Expenses - EUR | 5.849 | 304 | 400 | 4.751 | 1.851 | 2.049 | 52.689 | 7.681 | 9.077 | 12.384 |
| Gross Profit/Loss - EUR | 7.649 | 14.090 | 16.442 | 13.627 | 15.421 | 10.883 | 8.734 | 10.631 | 10.633 | 7.435 |
| Net Profit/Loss - EUR | 7.244 | 13.616 | 15.937 | 13.075 | 14.904 | 10.495 | 6.890 | 10.087 | 10.435 | 7.234 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 | 1 |
Check the financial reports for the company - A.c. Pharm Duo Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 18.718 | 18.527 | 18.213 | 57.731 | 56.613 | 55.540 | 35.211 | 29.947 | 29.856 | 54.628 |
| Current Assets | 413 | 11.925 | 27.663 | 29.543 | 37.129 | 31.405 | 47.172 | 60.839 | 71.142 | 53.165 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.430 | 3.074 | 2.761 | 3.057 | 2.991 | 1.707 | 1.713 | 68.743 | 49.908 |
| Cash | 413 | 10.495 | 24.590 | 26.782 | 34.073 | 28.414 | 45.465 | 59.126 | 2.399 | 3.258 |
| Shareholders Funds | 9.806 | 23.322 | 38.865 | 51.227 | 65.139 | 74.398 | 79.639 | 89.973 | 100.135 | 106.810 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 9.325 | 7.129 | 7.012 | 36.048 | 28.604 | 12.547 | 2.745 | 814 | 863 | 983 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - A.c. Pharm Duo Srl